Hautriwaic acidCAS# 18411-75-1 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 18411-75-1 | SDF | Download SDF |
| PubChem ID | 12310372 | Appearance | Powder |
| Formula | C20H28O4 | M.Wt | 332.44 |
| Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (4aR,5S,6R,8aS)-5-[2-(furan-3-yl)ethyl]-8a-(hydroxymethyl)-5,6-dimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid | ||
| SMILES | CC1CCC2(C(C1(C)CCC3=COC=C3)CCC=C2C(=O)O)CO | ||
| Standard InChIKey | PHKSUFCCGLWIMC-SIKIZQCASA-N | ||
| Standard InChI | InChI=1S/C20H28O4/c1-14-6-10-20(13-21)16(18(22)23)4-3-5-17(20)19(14,2)9-7-15-8-11-24-12-15/h4,8,11-12,14,17,21H,3,5-7,9-10,13H2,1-2H3,(H,22,23)/t14-,17-,19+,20-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Hautriwaic acid diminishes the joint edema induced by this mixture of polysaccharides (carrageenan), possibly by acting as immunomodulator of the inflammatory response. 2. Hautriwaic acid present in the methanolic extract and its ethyl acetate, and aqueous fractions may be responsible for this hepatoprotective activity of Dodonaea viscosa which was confirmed by in vivo experiments. 3. Hautriwaic acid shows anti-inflammatory activity in 12-O-tetradecanoylphorbol 13-acetate (TPA) mice ear edema models. |
| Targets | Immunology & Inflammation related |
Hautriwaic acid Dilution Calculator
Hautriwaic acid Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.0081 mL | 15.0403 mL | 30.0806 mL | 60.1612 mL | 75.2015 mL |
| 5 mM | 0.6016 mL | 3.0081 mL | 6.0161 mL | 12.0322 mL | 15.0403 mL |
| 10 mM | 0.3008 mL | 1.504 mL | 3.0081 mL | 6.0161 mL | 7.5202 mL |
| 50 mM | 0.0602 mL | 0.3008 mL | 0.6016 mL | 1.2032 mL | 1.504 mL |
| 100 mM | 0.0301 mL | 0.1504 mL | 0.3008 mL | 0.6016 mL | 0.752 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Isoleojaponin
Catalog No.:BCN7442
CAS No.:1840966-49-5
- Calystegine B4
Catalog No.:BCN1881
CAS No.:184046-85-3
- Dimeric coniferyl acetate
Catalog No.:BCN1148
CAS No.:184046-40-0
- sitaxsentan
Catalog No.:BCC1951
CAS No.:184036-34-8
- Ciproxifan maleate
Catalog No.:BCC4049
CAS No.:184025-19-2
- Ciproxifan
Catalog No.:BCC4539
CAS No.:184025-18-1
- Mithramycin A
Catalog No.:BCC2470
CAS No.:18378-89-7
- Cyanidin 3-sophoroside chloride
Catalog No.:BCN2611
CAS No.:18376-31-3
- Amyloid β-Protein (1-15)
Catalog No.:BCC1003
CAS No.:183745-81-5
- MRS 1220
Catalog No.:BCC6972
CAS No.:183721-15-5
- 1,2,3,4,5,6-Hexabromocyclohexane
Catalog No.:BCC2437
CAS No.:1837-91-8
- Penthiopyrad
Catalog No.:BCC8072
CAS No.:183675-82-3
- GB 2a
Catalog No.:BCN7425
CAS No.:18412-96-9
- SR 142948
Catalog No.:BCC7323
CAS No.:184162-64-9
- Dihydromorin
Catalog No.:BCN1149
CAS No.:18422-83-8
- Picfeltarraenin IV
Catalog No.:BCN2852
CAS No.:184288-35-5
- Vitisin B
Catalog No.:BCN6697
CAS No.:142449-90-9
- Cucurbitacin E
Catalog No.:BCN2300
CAS No.:18444-66-1
- Gefitinib
Catalog No.:BCN2173
CAS No.:184475-35-2
- Gefitinib hydrochloride
Catalog No.:BCC1591
CAS No.:184475-55-6
- Madecassic acid
Catalog No.:BCN1013
CAS No.:18449-41-7
- Bakkenolide B
Catalog No.:BCN7207
CAS No.:18455-98-6
- 1-Oxobakkenolide S
Catalog No.:BCN7114
CAS No.:18456-02-5
- Bakkenolide D
Catalog No.:BCN2909
CAS No.:18456-03-6
Anti-inflammatory activity of hautriwaic acid isolated from Dodonaea viscosa leaves.[Pubmed:22491678]
Molecules. 2012 Apr 10;17(4):4292-9.
The aim of this study was to identify an anti-inflammatory compound from D. viscosa leaves. The structure of this bioactive substance was elucidated by IR and NMR studies, which indicated that this natural product corresponds to Hautriwaic acid (HA). This diterpene exhibited good anti-inflammatory activity in 12-O-tetradecanoylphorbol 13-acetate (TPA) mice ear edema models by applications at doses of 0.25, 0.5 and 1.0 mg/ear (60.2, 70.2 and 87.1% inhibition, respectively); additionally Dodonaea viscosa dichloro-methane extract (DvDE) displays a 97.8% anti-inflammatory effect at 3 mg/kg. Multiple applications of DvDE at doses of 100 mg/kg on TPA mice ear edema inhibited the edema-associated inflammation by 71.8%, while HA at doses of 15 mg/kg, reduced edema to 64% and indomethacin 40%.
Effect of Hautriwaic Acid Isolated from Dodonaea viscosa in a Model of Kaolin/Carrageenan-Induced Monoarthritis.[Pubmed:26166136]
Planta Med. 2015 Sep;81(14):1240-7.
In the present work, the antiarthritic activity of Hautriwaic acid is reported. This ent-clerodane diterpene isolated from Dodonaea viscosa was evaluated in mice using a kaolin/carrageenan-induced monoarthritis model. The inflammation observed in the joint (knee) on days 1-8 ranged from 50-70 %. After 10 days of treatment with different doses of Hautriwaic acid (5, 10, 20 mg/kg), a decrease in knee inflammation was detected. This recovery was observed with both reference drugs, methotrexate (1 mg/kg) and diclofenac (0.75 mg/kg). In these groups of mice, the concentration of proinflammatory cytokines interleukin-1 beta, interleukin-6, and tumor necrosis factor alpha in the joint was significantly lower than that of the negative control group (animals with damage without any treatment). The negative control group presented a decrease in the concentration of interleukin-10, while the groups that received Hautriwaic acid at different dose exhibited an increase in this interleukin. This anti-inflammatory cytokine was not modified in the joint of mice with diclofenac, but in mice that received methotrexate, a significant decrease was observed. Hautriwaic acid isolated from D. viscosa diminished the joint edema induced by this mixture of polysaccharides (carrageenan), possibly by acting as immunomodulator of the inflammatory response.
Hautriwaic acid as one of the hepatoprotective constituent of Dodonaea viscosa.[Pubmed:24075215]
Phytomedicine. 2014 Jan 15;21(2):131-40.
It is widely known that hepatitis and its complications such as cirrhosis or hepatocellular carcinoma are one of the major health problems of the world especially since no specific treatment is available. In the present study we investigated the hepatoprotective potential of the methanolic extract of the whole plant of Dodonaea viscosa and its ethyl acetate, aqueous, butanol and n-hexane fractions against carbon tetrachloride (CCl(4)) induced hepatoxicity in rats. Hepatoprotection was assessed in terms of reduction in serum enzymes (ALT, AST, and ALP) that occur after CCl(4) injury, and by histopathology and immunohistochemistry. The methanolic extract reduced the serum enzyme level (ALT, AST, and ALP) down to control levels despite CCl(4) treatment. It also reduced the CCl(4)-induced damaged area to 0% as assessed by histopathology. The CD68+ macrophages were also reduced in number around the central vein area by the methanolic extract. These hepatoprotective effects were better than the positive control silymarin. Similar hepatoprotective activities were found with the ethyl acetate, and aqueous fractions of the methanolic extract. The butanol and n-hexane fractions showed elevated levels of ALT, AST and ALP as compared to the positive control silymarin. Histopathology showed approximately 30% damage to the liver cells with the butanol and n-hexane fractions which still showed some protective activity compared to the CCl(4) treated control. HPLC fingerprinting suggested that Hautriwaic acid present in the methanolic extract and its ethyl acetate, and aqueous fractions may be responsible for this hepatoprotective activity of Dodonaea viscosa which was confirmed by in vivo experiments.
